Fig. 2.
Fig. 2. Reactivity of PA autoantibodies with KO variant GPIIb-IIIa. / (A) Reaction of mAbs (AP3 and OP-G2) and antiplatelet alloantibodies (anti–HPA-1a and anti–HPA-3a) with KO variant GPIIb-IIIa. (B) PA autoantibodies from 11 patients with chronic ITP, showing a marked decrease (greater than 50%) in the reactivity against KO variant compared with WT GPIIb-IIIa. Results are expressed as ΔOD: [OD value obtained from a test sample − (mean + 3 SD) OD value obtained from 5 control samples]. Open columns represent ΔOD value in antigen-capture ELISA using WT GPIIb-IIIa, and filled columns represent ΔOD value in antigen-capture ELISA using KO mutant. Data are representative of 2 separate experiments.

Reactivity of PA autoantibodies with KO variant GPIIb-IIIa.

(A) Reaction of mAbs (AP3 and OP-G2) and antiplatelet alloantibodies (anti–HPA-1a and anti–HPA-3a) with KO variant GPIIb-IIIa. (B) PA autoantibodies from 11 patients with chronic ITP, showing a marked decrease (greater than 50%) in the reactivity against KO variant compared with WT GPIIb-IIIa. Results are expressed as ΔOD: [OD value obtained from a test sample − (mean + 3 SD) OD value obtained from 5 control samples]. Open columns represent ΔOD value in antigen-capture ELISA using WT GPIIb-IIIa, and filled columns represent ΔOD value in antigen-capture ELISA using KO mutant. Data are representative of 2 separate experiments.

Close Modal

or Create an Account

Close Modal
Close Modal